These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 7946067)

  • 1. Influence of a mutation in the transmembrane domain of the p185c-erbB2 oncogene-encoded protein studied by molecular dynamics simulations.
    Garnier N; Genest D; Hebert E; Genest M
    J Biomol Struct Dyn; 1994 Apr; 11(5):983-1002. PubMed ID: 7946067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transmembrane peptides from tyrosine kinase receptor. Mutation-related behavior in a lipid bilayer investigated by molecular dynamics simulations.
    Samna Soumana O; Aller P; Garnier N; Genest M
    J Biomol Struct Dyn; 2005 Aug; 23(1):91-100. PubMed ID: 15918680
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dimer interface of transmembrane domains for neu/erbB-2 receptor dimerization and transforming activation: a model revealed by molecular dynamics simulations.
    Sajot N; Genest M
    J Biomol Struct Dyn; 2001 Aug; 19(1):15-31. PubMed ID: 11565846
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detailed description of an alpha helix-->pi bulge transition detected by molecular dynamics simulations of the p185c-erbB2 V659G transmembrane domain.
    Duneau JP; Genest D; Genest M
    J Biomol Struct Dyn; 1996 Apr; 13(5):753-69. PubMed ID: 8723771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insight into signal transduction: structural alterations in transmembrane helices probed by multi-1 ns molecular dynamics simulations.
    Duneau JP; Garnier N; Genest M
    J Biomol Struct Dyn; 1997 Dec; 15(3):555-72. PubMed ID: 9440002
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular dynamics simulations of the transmembrane domain of the oncogenic ErbB2 receptor dimer in a DMPC bilayer.
    Garnier N; Crouzy S; Genest M
    J Biomol Struct Dyn; 2003 Oct; 21(2):179-200. PubMed ID: 12956604
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation of the structure of the transmembrane domain of the neu oncogene-encoded p185 protein with its function.
    Brandt-Rauf PW; Rackovsky S; Pincus MR
    Proc Natl Acad Sci U S A; 1990 Nov; 87(21):8660-4. PubMed ID: 1978329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conformational changes induced by the transforming amino acid substitution in the transmembrane domain of the neu oncogene-encoded p185 protein.
    Brandt-Rauf PW; Pincus MR; Chen JM
    J Protein Chem; 1989 Dec; 8(6):749-56. PubMed ID: 2576207
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A point mutation in the neu oncogene mimics ligand induction of receptor aggregation.
    Weiner DB; Liu J; Cohen JA; Williams WV; Greene MI
    Nature; 1989 May; 339(6221):230-1. PubMed ID: 2654648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dimerization of the p185neu transmembrane domain is necessary but not sufficient for transformation.
    Burke CL; Lemmon MA; Coren BA; Engelman DM; Stern DF
    Oncogene; 1997 Feb; 14(6):687-96. PubMed ID: 9038376
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of p185c-erbB-2 proto-oncogene expression by antisense oligodeoxynucleotides down-regulates p185-associated tyrosine-kinase activity and strongly inhibits mammary tumor-cell proliferation.
    Brysch W; Magal E; Louis JC; Kunst M; Klinger I; Schlingensiepen R; Schlingensiepen KH
    Cancer Gene Ther; 1994 Jun; 1(2):99-105. PubMed ID: 7621247
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlated motions and propagation of the effect of a local conformational change in the transmembrane helix of the c-erb B2 encoded protein and its V659E mutant, studied by molecular dynamics simulations.
    Garnier N; Genest D; Genest M
    Biophys Chem; 1996 Feb; 58(3):225-37. PubMed ID: 8820408
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transmembrane domain sequence requirements for activation of the p185c-neu receptor tyrosine kinase.
    Chen LI; Webster MK; Meyer AN; Donoghue DJ
    J Cell Biol; 1997 May; 137(3):619-31. PubMed ID: 9151669
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ERBB2 kinase domain mutation in the lung squamous cell carcinoma.
    Lee JW; Soung YH; Kim SY; Nam SW; Park WS; Wang YP; Jo KH; Moon SW; Song SY; Lee JY; Yoo NJ; Lee SH
    Cancer Lett; 2006 Jun; 237(1):89-94. PubMed ID: 16029927
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of mutations in the coding sequence of the proto-oncogene c-kit in a human mast cell leukemia cell line causing ligand-independent activation of c-kit product.
    Furitsu T; Tsujimura T; Tono T; Ikeda H; Kitayama H; Koshimizu U; Sugahara H; Butterfield JH; Ashman LK; Kanayama Y
    J Clin Invest; 1993 Oct; 92(4):1736-44. PubMed ID: 7691885
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A putative molecular-activation switch in the transmembrane domain of erbB2.
    Fleishman SJ; Schlessinger J; Ben-Tal N
    Proc Natl Acad Sci U S A; 2002 Dec; 99(25):15937-40. PubMed ID: 12461170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conformation of the transmembrane domain of the c-erbB-2 oncogene-encoded protein in its monomeric and dimeric states.
    Brandt-Rauf PW; Pincus MR; Monaco R
    J Protein Chem; 1995 Jan; 14(1):33-40. PubMed ID: 7779261
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular modeling of c-erbB2 receptor dimerization: coiled-coil structure of wild and oncogenic transmembrane domains--stabilization by interhelical hydrogen bonds in the oncogenic form.
    Garnier N; Genest D; Duneau JP; Genest M
    Biopolymers; 1997 Aug; 42(2):157-68. PubMed ID: 9234995
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Single point mutations in the SH2 domain impair the transforming potential of vav and fail to activate proto-vav.
    Katzav S
    Oncogene; 1993 Jul; 8(7):1757-63. PubMed ID: 8510922
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Specific short transmembrane sequences can inhibit transformation by the mutant neu growth factor receptor in vitro and in vivo.
    Lofts FJ; Hurst HC; Sternberg MJ; Gullick WJ
    Oncogene; 1993 Oct; 8(10):2813-20. PubMed ID: 8104327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.